Risk Assessment and Minimization for Progressive Multifocal Leukoencephalopathy (PML RAMP): A Program to Assess for Potential Early Signs and Symptoms of PML during Clinical Development of VedolizumabDavid Clifford, Asit Parikh, Kristin Stephens et al.|The American Journal of Gastroenterology|2013Cited by 8